Browsing Journal Articles by Author "Tegha, G"

Now showing items 1-2 of 2

    • Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial. 

      Jamieson, DJ; Chasela, CS; Hudgens, MG; King, CC; Kourtis, AP; Kayira, D; Hosseinipour, MC; Kamwendo, DD; Ellington, SR; Wiener, JB; Fiscus, SA; Tegha, G; Mofolo, IA; Sichali, DS; Adair, LS; Knight, RJ; Martinson, F; Kacheche, Z; Soko, A; Hoffman, I; van der Horst C, C; BAN study team.; Meme, J (University of Nairobi, 2012-06)
      BACKGROUND: In resource-limited settings where no safe alternative to breastfeeding exists, WHO recommends that antiretroviral prophylaxis be given to either HIV-infected mothers or infants throughout breastfeeding. We ...

    • Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. 

      Chasela, CS; Hudgens, MG; Jamieson, DJ; Kayira, D; Hosseinipour, MC; Kourtis, AP; Martinson, F; Tegha, G; Knight, RJ; Ahmed, Y; Kamwendo, DD; Hoffman, IF; Ellington, SR; Kacheche, Z; Soko, A; Wiener, JB; Fiscus, SA; Kazembe, P; Mofolo, IA; Chigwenembe, M; Sichali, DS; van der Horst, CM; BAN Study Group.; Meme, J (University of Nairobi, 2010-06)
      BACKGROUND: We evaluated the efficacy of a maternal triple-drug antiretroviral regimen or infant nevirapine prophylaxis for 28 weeks during breast-feeding to reduce postnatal transmission of human immunodeficiency virus ...